Scripps 7th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2024
- Free Shipping on orders over 45$
- In stock, ready to ship
- Inventory on the way
Scripps 7th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2024
Include: 29 videos + 1 pdf, size: 3.47 GBTarget Audience: cardiologists, oncologists
Information:
The Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive curriculum that addresses important clinical topics relevant to cardiomyopathy and the cardiovascular health of cancer patients and survivors. Cardio-oncology is an important and emerging field of medicine resulting from new or unexpected cardiovascular toxicities many cancer survivors are now experiencing because of their cancer treatments.
In addition, cardiac amyloidosis is a burgeoning disease with exciting new treatments. Nationally recognized faculty in the fields of cardiology and oncology will discuss challenging topics related to common cardiomyopathies as well as current best practices for diagnosing, treating and managing patients. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.
Educational Objectives
After attending this live activity, participants should be able to:
• Evaluate current and emerging treatment options for cardiac amyloidosis.
• Discuss diagnosis and treatment considerations for patients with cardiac sarcoidosis.
• Assess the importance of genetic testing and treatment for genetic cardiomyopathies including hypertrophic cardiomyopathy.
• Analyze best practices in the multidisciplinary monitoring and management of cardiac toxicity in patients undergoing cancer therapy.
• Employ management strategies for venous thromboembolism and other cardiovascular complications that may occur in patients with cancer.
• Demonstrate the importance of ongoing cardiac disease monitoring in cancer survivors.
The Scripps 7th Annual Cardiomyopathy and Cardio-Oncology Symposium 2024 is designed for a wide range of healthcare professionals interested in cardiomyopathy and cardio-oncology. The target audience includes:
- Physicians
- Cardiologists
- Oncologists
- Nurses
- Nurse practitioners
- Physician assistants
- Pharmacists
- Allied health professionals
This symposium focuses on the cardiovascular health of cancer patients and survivors, addressing important clinical topics and best practices for diagnosing, treating, and managing patients with cardiomyopathies and cardiovascular toxicities related to cancer treatments
Topics:
- brochure_cmp24.pdf
- SESSION I Cancer-Associated Thrombosis.mp4
- SESSION I Cardiotoxicity Anthracyclines.mp4
- SESSION I Cardiotoxicity Immunotherapy.mp4
- SESSION I Comprehensive Management of PE.mp4
- SESSION I Diagnosis of Sarcoid.mp4
- SESSION I HCM-Diagnosis and Treatment.mp4
- SESSION I Imaging of Sarcoid.mp4
- SESSION I MRI Imaging in Cardiotoxicity.mp4
- SESSION I Panel Discussion Q&A.mp4
- SESSION I Treatment of Sarcoid.mp4
- SESSION II Cardiac Amyloidosis Mimickers.mp4
- SESSION II MRI Imaging in Amyloid.mp4
- SESSION II Nuclear Imaging in Amyloid.mp4
- SESSION II Panel Discussion Q&A.mp4
- SESSION II What and When to Biopsy.mp4
- SESSION II When is MGUS Clinically Significant.mp4
- SESSION II When to Suspect Amyloidosis.mp4
- SESSION III AL Amyloidosis Current Treatments.mp4
- SESSION III Current Treatment of ATTR Silencers.mp4
- SESSION III Current Treatment of ATTR Stabilizers.mp4
- SESSION III Emerging ATTR Treatments.mp4
- SESSION III Panel Discussion Q&A.mp4
- SESSION III Racial and Geographic Disparities in Amyloid.mp4
- SESSION III Staging in Amyloid.mp4
- SESSION IV Carpal Tunnel in Amyloid.mp4
- SESSION IV Managing GI Issues in Amyloidosis.mp4
- SESSION IV Neuropathy and Dysautonomia in Amyloid.mp4
- SESSION IV Panel Discussion Q&A.mp4
- SESSION IV Transplant in Amyloidosis.mp4
- Orders under 45$ will have a shipping charge of a flat rate of 15$.
-Orders over 45$ will have Free Shipping.